Can a blood pressure drug ease POTS symptoms? new study investigates
NCT ID NCT04050410
First seen Mar 29, 2026 · Last updated Jun 18, 2026 · Updated 8 times
Summary
This study looks at how the sympathetic nervous system contributes to symptoms in people with Postural Tachycardia Syndrome (POTS), a condition that causes a rapid heart rate and discomfort when standing. Researchers will give participants a blood pressure medication called Moxonidine, which lowers sympathetic activity, to see if it reduces heart rate and improves symptoms. The goal is to better understand POTS and find more personalized treatments for the mostly young women affected.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTURAL TACHYCARDIA SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.